It’s another week for stakeholders to monitor what policy riders might be attached to FDA user fee reauthorization, which both parties plan to pass as part of temporary government funding legislation. Congress plans to use a continuing resolution to fund the government until mid-December, and user fee legislation is supposed to hitch a ride. But lawmakers haven’t offered many clues on whether policy riders will be included and how long the fees will be extended. Details might surface this week...